Syros Pharmaceuticals, Inc.
SYRS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$165 | -$95 | -$87 | -$84 |
| Dep. & Amort. | $2 | $3 | $3 | $3 |
| Deferred Tax | $0 | $0 | -$16 | $0 |
| Stock-Based Comp. | $10 | $11 | $10 | $11 |
| Change in WC | $5 | -$6 | -$11 | $10 |
| Other Non-Cash | $37 | -$37 | $1 | $2 |
| Operating Cash Flow | -$110 | -$123 | -$100 | -$57 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$51 | $0 | -$51 | $0 |
| Inv. Sales/Matur. | $87 | $68 | $0 | $50 |
| Other Inv. Act. | $2 | $0 | $0 | $0 |
| Investing Cash Flow | $37 | $67 | -$53 | $47 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | $39 |
| Stock Issued | $43 | $120 | $70 | $102 |
| Stock Repurch. | $0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $12 | $0 | $1 |
| Financing Cash Flow | $43 | $131 | $71 | $143 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$29 | $75 | -$82 | $132 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $171 | $95 | $177 | $45 |
| End Cash | $142 | $171 | $95 | $177 |
| Free Cash Flow | -$110 | -$124 | -$101 | -$61 |